ArticleJournal of neuroinflammation2026
Astrocytic Netrin-1 modulates stress-induced anxiety susceptibility in mice through ADAM17-mediated TNFα shedding.
Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Anxiety disorder is one of the most prevalent psychiatric diseases, with stress being a high-risk factor that functions by inducing neuroinflammation, particularly through the release of tumor necrosis factor α (TNFα). Although stress-induced transcription of TNFα is well documented, whether it also controls the proteolytic maturation of membrane-anchored TNFα precursor (proTNFα) remains unknown. Here we showed that the astrocyte-derived extracellular protein Netrin-1 was highly expressed in the mouse medial prefrontal cortex (mPFC) and down-regulated by restraint stress. Conditional knockout (cKO) of astrocytic Netrin-1 in astrocytes, both in embryo and adult, increased susceptibility to stress-induced anxiety. Mechanistically, Netrin-1 interacted with A disintegrin and metalloprotease 17 (ADAM17) and blocked ADAM17-mediated shedding of TNFα from proTNFα. Consequently, Netrin-1 deficiency elevated soluble TNFα and altered microglial morphology. Pharmacological neutralization of TNFα with Infliximab normalized anxiety-like phenotypes in stressed Netrin-1 cKO mice. Collectively, our data identify Netrin-1 as a critical brake on TNFα release and position the Netrin-1–ADAM17 axis as a tractable therapeutic target for TNFα-driven neuropsychiatric disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.